Restless Legs Syndrome: A Review of Diagnosis and Management in Primary Care

被引:20
作者
Bogan, Richard K. [1 ]
Cheray, James A. [2 ]
机构
[1] SleepMed Inc South Carolina, Columbia, SC 29201 USA
[2] Quivira Internal Med, Overland Pk, KS USA
关键词
diagnosis; management; sleep disturbance; periodic leg movements; dopamine receptor agonists; augmentation; PERIODIC LIMB MOVEMENTS; PLACEBO-CONTROLLED TRIAL; IRON-DEFICIENCY ALTERS; QUALITY-OF-LIFE; ROTIGOTINE TRANSDERMAL PATCH; LONG-TERM MANAGEMENT; SLEEP HEART HEALTH; DOUBLE-BLIND; OPEN-LABEL; SYNDROME RLS;
D O I
10.3810/pgm.2013.05.2636
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Restless legs syndrome (RLS) is a common neurological disorder that is characterized by an urge to move the legs (or arms), usually accompanied by uncomfortable and bothersome sensations in the affected limbs. The prevalence of RLS ranges from 7.2% to 11.5% in the general population, and its symptoms are frequent or severe enough to require medical treatment by approximately 3% of the population. However, RLS remains largely undiagnosed, perhaps due to a lack of understanding of RLS as a medically significant disorder. Restless legs syndrome can have serious clinical consequences and a significant impact on patients' quality of life, and therefore correct diagnosis and appropriate management are important. The symptoms of RLS can be managed effectively by treatment. In this review article, we provide a description of RLS and the 4 diagnostic criteria, including a discussion of differentiating symptoms and other medical conditions that mimic RLS. We review the evidence regarding the clinical impact of RLS on sleep disturbance, patients' overall health and quality of life, and the disorder's association with cardiovascular risk. The current focus of RLS therapy is to provide symptom relief; we discuss the available pharmacologic treatment options for RLS, with a focus on the clinical evidence surrounding non-ergot-derived dopamine receptor agonists, which are the current agents of choice for moderate-to-severe RLS. Finally, we consider when it may be most appropriate for the primary care physician to refer a patient with RLS to a specialist.
引用
收藏
页码:99 / 111
页数:13
相关论文
共 118 条
[1]   Evaluating the quality of life of patients with restless legs syndrome [J].
Abetz, L ;
Allen, R ;
Follet, A ;
Washburn, T ;
Earley, C ;
Kirsch, J ;
Knight, H .
CLINICAL THERAPEUTICS, 2004, 26 (06) :925-935
[2]   TREATMENT OF RESTLESS LEGS SYNDROME WITH LEVODOPA PLUS BENSERAZIDE [J].
AKPINAR, S .
ARCHIVES OF NEUROLOGY, 1982, 39 (11) :739-739
[3]  
ALI NJ, 1991, SLEEP, V14, P163
[4]   Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome [J].
Allen, R ;
Becker, PM ;
Bogan, R ;
Schmidt, M ;
Kushida, CA ;
Fry, JM ;
Poceta, JS ;
Winslow, D .
SLEEP, 2004, 27 (05) :907-914
[5]   The role of iron in restless legs syndrome [J].
Allen, Richard P. ;
Earley, Christopher J. .
MOVEMENT DISORDERS, 2007, 22 :S440-S448
[6]   Prevalence and Disease Burden of Primary Restless Legs Syndrome: Results of a General Population Survey in the United States [J].
Allen, Richard P. ;
Bharmal, Murtuza ;
Calloway, Michael .
MOVEMENT DISORDERS, 2011, 26 (01) :114-120
[7]   Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: Prevalence and characteristics [J].
Allen, Richard P. ;
Stillman, Paul ;
Myers, Andrew J. .
SLEEP MEDICINE, 2010, 11 (01) :31-37
[8]   Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology - A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health [J].
Allen, RP ;
Picchietti, D ;
Hening, WA ;
Trenkwalder, C ;
Walters, AS ;
Montplaisi, J .
SLEEP MEDICINE, 2003, 4 (02) :101-119
[9]   Restless legs syndrome prevalence and impact - REST general population study [J].
Allen, RP ;
Walters, AS ;
Montplaisir, J ;
Hening, W ;
Myers, A ;
Bell, TJ ;
Ferini-Strambi, L .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (11) :1286-1292
[10]   Augmentation of the restless legs syndrome with carbidopa/levodopa [J].
Allen, RP ;
Earley, CJ .
SLEEP, 1996, 19 (03) :205-213